{"schema_version":"secwatch.filing_event.v1","accession":"0001827090-25-000018","form_type":"8-K","ticker":"CERT","cik":"0001827090","company_name":"Certara, Inc.","filed_at":"2025-03-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.116276+00:00","generated_at":"2026-05-25T11:13:57.059233+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Certara President Patrick F. Smith steps down, moves to senior advisory role","bullets":["Dr. Patrick F. Smith stepped down as President, Certara Drug Development Solutions, effective March 3, 2025.","Smith remains employed at Certara in a senior advisory and scientific capacity.","No replacement for the President role was announced in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001827090-25-000018","json":"https://secwatch.observer/filing/0001827090-25-000018.json","markdown":"https://secwatch.observer/filing/0001827090-25-000018.md","text":"https://secwatch.observer/filing/0001827090-25-000018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1827090/000182709025000018/0001827090-25-000018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1827090/000182709025000018/certara-20250303.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T11:13:57.059233+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"80501197d0","claim":"Dr. Patrick F. Smith departed as President, Certara Drug Development Solutions at Certara, Inc..","evidence_excerpt":"On March 5, 2025, Certara, Inc. (the “Company”) announced that Dr. Patrick F. Smith, President, Certara Drug Development Solutions, stepped down from that role as of March 3, 2025, but will remain employed by the Company in a senior advisory and scientific role.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1827090/000182709025000018/0001827090-25-000018-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"President, Certara Drug Development Solutions"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}